Actual use of anti-MRSA drugs in Japan with the focus on arbekacin

Kihachiro Shimizu, Naoki Aikawa, Yusuke Tanigawara, Mitsuo Kaku, Masafumi Imae, Nobusuke Nishizawa, Hiroshi Nakamura